D-0146-2020 Class II Terminated

Recalled by Ingenus Pharmaceuticals Llc — Orlando, FL

FDA drug recall D-0146-2020 was initiated by Ingenus Pharmaceuticals Llc on Oct 9, 2019 and is designated Class II. Reason for recall: Crystallization: Presence of particulate matter identified as API crystallization The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 16485 vials.

Recall details

Product Type
Drugs
Report Date
Oct 23, 2019
Initiation Date
Oct 9, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16485 vials

Product description

Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839

Reason for recall

Crystallization: Presence of particulate matter identified as API crystallization

Distribution pattern

U.S.A. Nationwide

Code information

Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0146-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0146-2020. Report a data issue: hello@regdatalab.com.